| balneotherapy |
001 |
| knee osteoarthritis |
001 |
| sleep disturbance |
001 |
| sleep quality |
001 |
| client-centered approach |
006 |
| occupational therapy |
006 |
| rheumatoid arthritis |
006, 055, 064, 076 |
| ankylosing spondylitis |
024, 041, 087 |
| delayed diagnosis |
024 |
| outcome |
024 |
| quality of life |
024, 041 |
| arterial stiffness |
031 |
| cluster of differentiation 146 |
031 |
| pulse wave velocity |
031 |
| systemic lupus erythematosus |
031 |
| chronic disease |
041 |
| depression |
041 |
| females |
041 |
| sexual dysfunction |
041 |
| behçet’s disease |
048 |
| manganese superoxide dismutase |
048 |
| polymerase chain reaction-restriction fragment length polymorphism |
048 |
| polymorphism |
048 |
| connexin 43 |
055 |
| gap junction |
055 |
| pro-inflammatory cytokine |
055 |
| synovial tissue |
055 |
| anti-cyclic citrullinated peptide antibody |
064 |
| vitamin d |
064 |
| hyperuricemia |
071 |
| lead exposure |
071 |
| renal function |
071 |
| saturnine gout |
071 |
| uric acid |
071 |
| 4-hydroxynonenal |
076 |
| disease activity |
076 |
| modified larsen score |
076 |
| anomalies |
082 |
| klippel-feil syndrome |
082 |
| neurological symptoms |
082 |
| trauma |
082 |
| autoimmune diseases |
087 |
| sjogren’s syndrome |
087 |
| corticosteroid |
091 |
| cyclophosphamide |
091 |
| longitudinal myelitis |
091 |
| magnetic resonance imaging |
091 |
| neuro-behçet’s disease |
091 |
| methotrexate |
094 |
| psoriatic arthritis |
094 |
| psoriatic onycho-pachydermo-periostitis |
094 |
| variant |
094 |
| pulmonary endarterectomy |
098 |
| pulmonary hypertension |
098 |
| takayasu’s arteritis |
098 |
